Modulation of the Immune Response to Improve Health and Reduce Foodborne Pathogens in Poultry.
Christina L SwaggertyTodd Riley CallawayMichael H KogutAndrea PivaEster GrilliPublished in: Microorganisms (2019)
Salmonella and Campylobacter are the two leading causes of bacterial-induced foodborne illness in the US. Food production animals including cattle, swine, and chickens are transmission sources for both pathogens. The number of Salmonella outbreaks attributed to poultry has decreased. However, the same cannot be said for Campylobacter where 50⁻70% of human cases result from poultry products. The poultry industry selects heavily on performance traits which adversely affects immune competence. Despite increasing demand for poultry, regulations and public outcry resulted in the ban of antibiotic growth promoters, pressuring the industry to find alternatives to manage flock health. One approach is to incorporate a program that naturally enhances/modulates the bird's immune response. Immunomodulation of the immune system can be achieved using a targeted dietary supplementation and/or feed additive to alter immune function. Science-based modulation of the immune system targets ways to reduce inflammation, boost a weakened response, manage gut health, and provide an alternative approach to prevent disease and control foodborne pathogens when conventional methods are not efficacious or not available. The role of immunomodulation is just one aspect of an integrated, coordinated approach to produce healthy birds that are also safe and wholesome products for consumers.
Keyphrases
- antimicrobial resistance
- immune response
- public health
- healthcare
- mental health
- escherichia coli
- gram negative
- endothelial cells
- health information
- oxidative stress
- health promotion
- dendritic cells
- toll like receptor
- biofilm formation
- heat stress
- drinking water
- cancer therapy
- staphylococcus aureus
- cystic fibrosis
- genome wide
- gene expression
- quality improvement
- multidrug resistant
- social media
- pseudomonas aeruginosa
- adverse drug